| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YEXMP.2017.02.009 |
| P698 | PubMed publication ID | 28214514 |
| P50 | author | Ian J Frew | Q40142922 |
| Holger Moch | Q90210393 | ||
| Tullio Sulser | Q92006035 | ||
| P2093 | author name string | Thomas Hermanns | |
| Peter J Wild | |||
| Thomas Winder | |||
| Markus Rechsteiner | |||
| Tomas Hejhal | |||
| Cédric Poyet | |||
| Gerald Prager | |||
| Claudia Corrò | |||
| P2860 | cites work | Cancer treatment and survivorship statistics, 2012 | Q27020961 |
| Integrated molecular analysis of clear-cell renal cell carcinoma | Q27852382 | ||
| Circulating mutant DNA to assess tumor dynamics | Q28289337 | ||
| Detection of circulating tumor DNA in early- and late-stage human malignancies | Q29615778 | ||
| Identification of the von Hippel-Lindau disease tumor suppressor gene | Q29618644 | ||
| Detection and quantification of rare mutations with massively parallel sequencing | Q30472217 | ||
| Quantitative identification of mutant alleles derived from lung cancer in plasma cell-free DNA via anomaly detection using deep sequencing data | Q30701832 | ||
| Molecular genetics of clear-cell renal cell carcinoma | Q33729097 | ||
| Detection and quantification of mutations in the plasma of patients with colorectal tumors | Q34132363 | ||
| Cell-free nucleic acids as biomarkers in cancer patients | Q34184393 | ||
| Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. | Q34278191 | ||
| Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors | Q37069569 | ||
| Quantification of plasma cell-free DNA in predicting therapeutic efficacy of sorafenib on metastatic clear cell renal cell carcinoma | Q37260676 | ||
| Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney | Q37349768 | ||
| Cell-free DNA in the blood as a solid tumor biomarker--a critical appraisal of the literature. | Q37778114 | ||
| Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunities | Q38159131 | ||
| KRAS, BRAF, and TP53 deep sequencing for colorectal carcinoma patient diagnostics | Q38453969 | ||
| VHL gene mutations and their effects on hypoxia inducible factor HIFα: identification of potential driver and passenger mutations | Q39515837 | ||
| The Roles of VHL-Dependent Ubiquitination in Signaling and Cancer | Q41911531 | ||
| Mutations of the VHL tumour suppressor gene in renal carcinoma | Q42806703 | ||
| Free circulating tumor DNA as a diagnostic marker for breast cancer. | Q46790581 | ||
| Quantitative analysis of plasma DNA in colorectal cancer patients: a novel prognostic tool. | Q51104081 | ||
| Serum cell-free DNA in renal cell carcinoma: a diagnostic and prognostic marker. | Q54578238 | ||
| Concentration and microsatellite status of plasma DNA for monitoring patients with renal carcinoma | Q62837556 | ||
| Detection and monitoring of cell-free DNA in blood of patients with colorectal cancer | Q82218655 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 255-261 | |
| P577 | publication date | 2017-02-23 | |
| P1433 | published in | Experimental and Molecular Pathology | Q15767470 |
| P1476 | title | Detecting circulating tumor DNA in renal cancer: An open challenge | |
| P478 | volume | 102 |
| Q54996932 | A Next-Generation Sequencing Primer-How Does It Work and What Can It Do? |
| Q58766362 | Circulating Tumor Cells for the Management of Renal Cell Carcinoma |
| Q89945283 | Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors |
| Q92127946 | Evaluating the cerebrospinal fluid ctDNA detection by next-generation sequencing in the diagnosis of meningeal Carcinomatosis |
| Q55023971 | Single-cell genetic analysis validates cytopathological identification of circulating cancer cells in patients with clear cell renal cell carcinoma. |
Search more.